Location History:
- Beringen, CH (2019)
- Schaffhausen, CH (2020 - 2022)
Company Filing History:
Years Active: 2019-2022
Title: Thierry Francois Alain Jean Jousseaume: Innovator in Pharmaceutical Chemistry
Introduction
Thierry Francois Alain Jean Jousseaume is a notable inventor based in Schaffhausen, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit phosphoinositide-3-kinase activity. With a total of four patents to his name, Jousseaume's work is recognized for its potential therapeutic applications.
Latest Patents
Among his latest patents is the invention of (R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxaline-6-carboxamide. This compound is designed to inhibit phosphoinositide-3-kinase activity, showcasing its utility as a pI3Kβ inhibitor. The invention also encompasses pharmaceutical compositions that include these compounds as active ingredients, highlighting their potential use as medicaments. Another patent focuses on quinoxaline and pyridopyrazine derivatives, further emphasizing their role as pI3Kβ inhibitors.
Career Highlights
Jousseaume is currently associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work at Janssen has allowed him to explore innovative solutions in drug development, contributing to advancements in medical science.
Collaborations
Throughout his career, Jousseaume has collaborated with esteemed colleagues such as Lieven Meerpoel and Patrick Rene Angibaud. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Thierry Francois Alain Jean Jousseaume stands out as a prominent inventor in the pharmaceutical field, with a focus on developing compounds that have significant therapeutic potential. His contributions continue to impact the industry positively.